{"transactions":[{"id":4134004,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":171198,"kind":"person","name":"Terifay Robert J","position":1,"cik":"0001391382","reported_name":"Terifay Robert J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Commercial"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2017-12-13T21:52:29.000Z","date":"2017-12-12","kind":"grant","acquired":true,"shares":32300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option award vests in four equal annual installments, commencing one year after the date of grant."}],"balance_after":32300,"derivative":{"exercise_price":378.98,"expiration_date":"2027-12-12","underlying":"Common Stock","underlying_shares":32300},"source":{"system":"sec-edgar","filing":"0001237899-17-000026","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872589/000123789917000026/edgardoc.xml","form_type":"4"}},{"id":4237069,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":171198,"kind":"person","name":"Terifay Robert J","position":1,"cik":"0001391382","reported_name":"Terifay Robert J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Commercial"}}],"security":"Incentive Stock Option (right to buy)","published_at":"2017-08-11T20:02:52.000Z","date":"2017-08-10","kind":"exercise","acquired":false,"shares":1921,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option award (combined incentive stock option and non-qualified stock option) vests in four equal annual installments, commencing one year after the date of grant."}],"balance_after":0,"derivative":{"exercise_price":52.03,"expiration_date":"2021-12-16","underlying":"Common Stock","underlying_shares":1921},"source":{"system":"sec-edgar","filing":"0001708138-17-000013","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813817000013/edgardoc.xml","form_type":"4"}},{"id":4237068,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":171198,"kind":"person","name":"Terifay Robert J","position":1,"cik":"0001391382","reported_name":"Terifay Robert J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Commercial"}}],"security":"Common Stock","published_at":"2017-08-11T20:02:52.000Z","date":"2017-08-10","kind":"exercise","acquired":true,"shares":1921,"price":52.03,"value":99949.63,"ownership":{"direct":true},"balance_after":25214,"source":{"system":"sec-edgar","filing":"0001708138-17-000013","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813817000013/edgardoc.xml","form_type":"4"}},{"id":4278197,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":171198,"kind":"person","name":"Terifay Robert J","position":1,"cik":"0001391382","reported_name":"Terifay Robert J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Commercial"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2017-06-19T20:44:26.000Z","date":"2017-06-15","kind":"exercise","acquired":false,"shares":48750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option became exercisable with respect to all shares underlying the option on December 31, 2014, based upon the satisfaction by the company of certain performance criteria during the period ended December 31, 2014."}],"balance_after":30579,"derivative":{"exercise_price":52.03,"expiration_date":"2021-12-16","underlying":"Common Stock","underlying_shares":48750},"source":{"system":"sec-edgar","filing":"0001708138-17-000007","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813817000007/edgardoc.xml","form_type":"4"}},{"id":4278196,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":171198,"kind":"person","name":"Terifay Robert J","position":1,"cik":"0001391382","reported_name":"Terifay Robert J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Commercial"}}],"security":"Common Stock","published_at":"2017-06-19T20:44:26.000Z","date":"2017-06-16","kind":"sale","acquired":false,"shares":21147,"price":468.19,"value":9900813.93,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."}],"balance_after":23293,"source":{"system":"sec-edgar","filing":"0001708138-17-000007","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813817000007/edgardoc.xml","form_type":"4"}},{"id":4278195,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":171198,"kind":"person","name":"Terifay Robert J","position":1,"cik":"0001391382","reported_name":"Terifay Robert J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Commercial"}}],"security":"Common Stock","published_at":"2017-06-19T20:44:26.000Z","date":"2017-06-15","kind":"tax_withholding","acquired":false,"shares":22192,"price":468.69,"value":10401168.48,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."}],"balance_after":44440,"source":{"system":"sec-edgar","filing":"0001708138-17-000007","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813817000007/edgardoc.xml","form_type":"4"}},{"id":4278194,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":171198,"kind":"person","name":"Terifay Robert J","position":1,"cik":"0001391382","reported_name":"Terifay Robert J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Commercial"}}],"security":"Common Stock","published_at":"2017-06-19T20:44:26.000Z","date":"2017-06-15","kind":"tax_withholding","acquired":false,"shares":5411,"price":468.69,"value":2536081.59,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."}],"balance_after":66632,"source":{"system":"sec-edgar","filing":"0001708138-17-000007","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813817000007/edgardoc.xml","form_type":"4"}},{"id":4278193,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":171198,"kind":"person","name":"Terifay Robert J","position":1,"cik":"0001391382","reported_name":"Terifay Robert J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Commercial"}}],"security":"Common Stock","published_at":"2017-06-19T20:44:26.000Z","date":"2017-06-15","kind":"exercise","acquired":true,"shares":48750,"price":52.03,"value":2536462.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."}],"balance_after":72043,"source":{"system":"sec-edgar","filing":"0001708138-17-000007","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813817000007/edgardoc.xml","form_type":"4"}},{"id":4517637,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":171198,"kind":"person","name":"Terifay Robert J","position":1,"cik":"0001391382","reported_name":"Terifay Robert J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Commercial"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2016-12-19T21:16:07.000Z","date":"2016-12-16","kind":"grant","acquired":true,"shares":34000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option award vests in four equal annual installments, commencing one year after the date of grant."}],"balance_after":34000,"derivative":{"exercise_price":381.92,"expiration_date":"2026-12-16","underlying":"Common Stock","underlying_shares":34000},"source":{"system":"sec-edgar","filing":"0001237899-16-000090","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872589/000123789916000090/edgardoc.xml","form_type":"4"}}]}